These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 23682851

  • 1. Epstein-Barr virus-associated smooth muscle tumors after kidney transplantation: treatment and outcomes in a single center.
    Tan CS, Loh HL, Foo MW, Choong LH, Wong KS, Kee TY.
    Clin Transplant; 2013; 27(4):E462-8. PubMed ID: 23682851
    [Abstract] [Full Text] [Related]

  • 2. A rare case of Epstein-Barr virus-associated hepatosplenic smooth muscle tumors after kidney transplantation.
    Pircher C, Schneeberger S, Boesmueller C, Agaimy A, Zoller H, Bale R, Henninger B, Mayer G, Neuwirt H.
    Transpl Infect Dis; 2018 Jun; 20(3):e12860. PubMed ID: 29427352
    [Abstract] [Full Text] [Related]

  • 3. Use of sirolimus for Epstein-Barr virus-positive smooth-muscle tumour.
    Toh HC, Teo M, Ong KW, Lee V, Chan E, Lee AS, Vathsala A.
    Lancet Oncol; 2006 Nov; 7(11):955-7. PubMed ID: 17081922
    [No Abstract] [Full Text] [Related]

  • 4. The utilization of sirolimus and the impact on wound-healing complications in obese kidney transplant recipients.
    Hulbert AL, Delahunty AJ, Rajab A, Forbes RC, Winters HA.
    Clin Transplant; 2013 Nov; 27(4):E521-7. PubMed ID: 23923974
    [Abstract] [Full Text] [Related]

  • 5. Treatment response with sirolimus for a pediatric patient with an EBV-associated smooth-muscle tumor after bone marrow transplantation.
    Penney SW, Bishop BN, Howell DL.
    Pediatr Blood Cancer; 2019 May; 66(5):e27585. PubMed ID: 30614215
    [Abstract] [Full Text] [Related]

  • 6. Association of Baseline Viral Serology and Sirolimus Regimens With Kidney Transplant Outcomes: A 14-Year Registry-Based Cohort Study in the United States.
    Santos AH, Casey MJ, Xuerong W, Womer KL.
    Transplantation; 2017 Feb; 101(2):377-386. PubMed ID: 28121742
    [Abstract] [Full Text] [Related]

  • 7. Synchronous hepatic, mesenteric and pulmonary Epstein-Barr virus-associated smooth muscle tumors in a renal transplant recipient.
    Al Hussain T, Haleem A, Alsaad KO.
    Clin Transplant; 2010 Feb; 24(5):579-84. PubMed ID: 20156224
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus associated smooth muscle tumors in solid organ transplant recipients: Incidence over 31 years at a single institution and review of the literature.
    Stubbins RJ, Alami Laroussi N, Peters AC, Urschel S, Dicke F, Lai RL, Zhu J, Mabilangan C, Preiksaitis JK.
    Transpl Infect Dis; 2019 Feb; 21(1):e13010. PubMed ID: 30298678
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-associated smooth muscle tumors after lung transplantation.
    Hirama T, Tikkanen J, Pal P, Cleary S, Binnie M.
    Transpl Infect Dis; 2019 Jun; 21(3):e13068. PubMed ID: 30864272
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus-associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient.
    Conrad A, Brunet AS, Hervieu V, Chauvet C, Buron F, Collardeau-Frachon S, Rivet C, Cassier P, Testelin S, Lachaux A, Morelon E, Thaunat O.
    Transpl Infect Dis; 2013 Oct; 15(5):E182-6. PubMed ID: 24034213
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus-associated smooth muscle tumor in a kidney transplant recipient: A case-report and review of the literature.
    Tardieu L, Meatchi T, Meyer L, Grataloup C, Bernard-Tessier A, Karras A, Thervet E, Lazareth H.
    Transpl Infect Dis; 2021 Feb; 23(1):e13456. PubMed ID: 32881184
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
    Doesch AO, Konstandin M, Celik S, Kristen A, Frankenstein L, Sack FU, Schnabel P, Schnitzler P, Katus HA, Dengler TJ.
    Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus-associated smooth muscle tumors in children following solid organ transplantation: a review.
    Jossen J, Chu J, Hotchkiss H, Wistinghausen B, Iyer K, Magid M, Kamath A, Roayaie S, Arnon R.
    Pediatr Transplant; 2015 Mar; 19(2):235-43. PubMed ID: 25572657
    [Abstract] [Full Text] [Related]

  • 14. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C, Giacchino F, Bergallo M, Bonello F, Bollero C, Segoloni GP, Cavallo R.
    G Ital Nefrol; 2003 Mar; 20(2):170-5. PubMed ID: 12746803
    [Abstract] [Full Text] [Related]

  • 15. "Epstein-Barr virus associated smooth muscle tumour as an unusual cause of ureteric graft obstruction in a child".
    Szklarz MT, Tessi C, Ruiz J, Rosiere NI, Lopez Imizcoz F, Weller S, Solernou VE, Monteverde ML, Corbetta JP.
    Pediatr Transplant; 2021 Dec; 25(8):e14109. PubMed ID: 34363296
    [Abstract] [Full Text] [Related]

  • 16. Cytomegalovirus & Epstein Barr Virus serostatus as a predictor of the long-term outcome of kidney transplantation.
    Le Page AK, Mackie FE, McTaggart SJ, Kennedy SE.
    Nephrology (Carlton); 2013 Dec; 18(12):813-9. PubMed ID: 23927085
    [Abstract] [Full Text] [Related]

  • 17. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A, Jiménez L, Aranda I, Alvarez L, González M, Rocamora N, Olivares J.
    Nefrologia; 2002 Dec; 22(5):463-9. PubMed ID: 12497748
    [Abstract] [Full Text] [Related]

  • 18. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
    Pliszczynski J, Kahan BD.
    Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822
    [Abstract] [Full Text] [Related]

  • 19. Expression of EBV latent antigens, mammalian target of rapamycin, and tumor suppression genes in EBV-positive smooth muscle tumors: clinical and therapeutic implications.
    Ong KW, Teo M, Lee V, Ong D, Lee A, Tan CS, Vathsala A, Toh HC.
    Clin Cancer Res; 2009 Sep 01; 15(17):5350-8. PubMed ID: 19706821
    [Abstract] [Full Text] [Related]

  • 20. Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience.
    Moscarelli L, Caroti L, Antognoli G, Zanazzi M, Di Maria L, Carta P, Minetti E.
    Clin Transplant; 2013 Sep 01; 27(4):546-54. PubMed ID: 23758330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.